Nepal approves use of Covishield vaccine manufactured in India
India
Updated: Friday, January 15, 2021, 19:59 [IST]
New Delhi, Jan 15: Nepal on Friday granted approval for AstraZeneca s COVISHIELD vaccine against the novel coronavirus in the country.
Representational Image
The decision to grant the approval for the vaccine was taken on Friday, Nepal s Department of Drug Administration (DDA) said in a statement. Conditional permission has been granted for emergency use authorisation of Covishield vaccine against COVID-19 in Nepal, the statement said.
Drug major AstraZeneca has partnered with the Pune-based Serum Institute of India (SII), the world s largest vaccine manufacturer, for the supply of the vaccine to the Indian government and also to a large number of low and middle-income countries.